Perceptions About Biosimilar Medicines Among Belgian Patients in the Ambulatory Care

Background and objectives: Biosimilar medicines have been on the European market for 15 years. Despite the extensive and positive experience with biosimilars across Europe, their uptake remains limited in Belgium. One of the possible factors limiting uptake in clinical practice is the inadequate und...

Descripción completa

Detalles Bibliográficos
Autores principales: Vandenplas, Yannick, Barbier, Liese, Simoens, Steven, Van Wilder, Philippe, Vulto, Arnold G., Huys, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766979/
https://www.ncbi.nlm.nih.gov/pubmed/35069205
http://dx.doi.org/10.3389/fphar.2021.789640

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766979/
https://www.ncbi.nlm.nih.gov/pubmed/35069205
http://dx.doi.org/10.3389/fphar.2021.789640

Ejemplares similares